

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 7.76474971 |
| 2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.00102907 |
| 3 | glomerular visceral epithelial cell development (GO:0072015) | 6.05657840 |
| 4 | heme biosynthetic process (GO:0006783) | 5.19192439 |
| 5 | glomerular epithelial cell development (GO:0072310) | 5.13770379 |
| 6 | porphyrin-containing compound biosynthetic process (GO:0006779) | 5.12322779 |
| 7 | hemidesmosome assembly (GO:0031581) | 5.11968242 |
| 8 | skin morphogenesis (GO:0043589) | 4.66767033 |
| 9 | tetrapyrrole biosynthetic process (GO:0033014) | 4.40396943 |
| 10 | glomerular basement membrane development (GO:0032836) | 4.37888464 |
| 11 | heme metabolic process (GO:0042168) | 4.12209125 |
| 12 | erythrocyte maturation (GO:0043249) | 4.09925070 |
| 13 | porphyrin-containing compound metabolic process (GO:0006778) | 4.07570758 |
| 14 | regulation of early endosome to late endosome transport (GO:2000641) | 4.01695255 |
| 15 | cell-substrate junction assembly (GO:0007044) | 3.94823697 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 3.89330477 |
| 17 | skeletal muscle tissue regeneration (GO:0043403) | 3.87504557 |
| 18 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.80098345 |
| 19 | hemoglobin metabolic process (GO:0020027) | 3.70490799 |
| 20 | protein localization to endosome (GO:0036010) | 3.60105762 |
| 21 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.57793035 |
| 22 | atrioventricular valve morphogenesis (GO:0003181) | 3.56241383 |
| 23 | response to arsenic-containing substance (GO:0046685) | 3.53621544 |
| 24 | hypotonic response (GO:0006971) | 3.47312131 |
| 25 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.46581976 |
| 26 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.42677010 |
| 27 | muscle cell fate commitment (GO:0042693) | 3.42293103 |
| 28 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.38054295 |
| 29 | wound healing, spreading of epidermal cells (GO:0035313) | 3.31742721 |
| 30 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.30451926 |
| 31 | desmosome organization (GO:0002934) | 3.29647854 |
| 32 | endothelial cell chemotaxis (GO:0035767) | 3.22579659 |
| 33 | hepatocyte apoptotic process (GO:0097284) | 3.21155745 |
| 34 | * positive regulation of p38MAPK cascade (GO:1900745) | 3.18127062 |
| 35 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.15654982 |
| 36 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.15641743 |
| 37 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.14104345 |
| 38 | positive regulation of astrocyte differentiation (GO:0048711) | 3.11577371 |
| 39 | erythrocyte development (GO:0048821) | 3.02558893 |
| 40 | cellular response to arsenic-containing substance (GO:0071243) | 2.99629146 |
| 41 | ER overload response (GO:0006983) | 2.99002879 |
| 42 | skeletal muscle contraction (GO:0003009) | 2.97912547 |
| 43 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.96859698 |
| 44 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.96027909 |
| 45 | platelet aggregation (GO:0070527) | 2.94843077 |
| 46 | cell-substrate adherens junction assembly (GO:0007045) | 2.92889168 |
| 47 | focal adhesion assembly (GO:0048041) | 2.92889168 |
| 48 | ribosomal small subunit biogenesis (GO:0042274) | 2.92459433 |
| 49 | endocytic recycling (GO:0032456) | 2.91278696 |
| 50 | angiogenesis involved in wound healing (GO:0060055) | 2.90943139 |
| 51 | Golgi transport vesicle coating (GO:0048200) | 2.89516010 |
| 52 | COPI coating of Golgi vesicle (GO:0048205) | 2.89516010 |
| 53 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.88574118 |
| 54 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.87417672 |
| 55 | trophoblast giant cell differentiation (GO:0060707) | 2.85524492 |
| 56 | platelet degranulation (GO:0002576) | 2.85039387 |
| 57 | peptidyl-proline hydroxylation (GO:0019511) | 2.84668060 |
| 58 | actin-myosin filament sliding (GO:0033275) | 2.83627489 |
| 59 | muscle filament sliding (GO:0030049) | 2.83627489 |
| 60 | protein neddylation (GO:0045116) | 2.81559983 |
| 61 | stress fiber assembly (GO:0043149) | 2.81526910 |
| 62 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.81419961 |
| 63 | mRNA transcription (GO:0009299) | 2.81367320 |
| 64 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.80755762 |
| 65 | cell adhesion mediated by integrin (GO:0033627) | 2.80351769 |
| 66 | endodermal cell differentiation (GO:0035987) | 2.79118457 |
| 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78315246 |
| 68 | membrane raft organization (GO:0031579) | 2.77718240 |
| 69 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77658495 |
| 70 | adherens junction assembly (GO:0034333) | 2.74576318 |
| 71 | adhesion of symbiont to host (GO:0044406) | 2.73983153 |
| 72 | protein hydroxylation (GO:0018126) | 2.72462364 |
| 73 | erythrocyte differentiation (GO:0030218) | 2.72442360 |
| 74 | * regulation of p38MAPK cascade (GO:1900744) | 2.72359748 |
| 75 | epithelial cell-cell adhesion (GO:0090136) | 2.71355648 |
| 76 | granulocyte activation (GO:0036230) | 2.70029095 |
| 77 | decidualization (GO:0046697) | 2.69968331 |
| 78 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.69690012 |
| 79 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.68517137 |
| 80 | fibrinolysis (GO:0042730) | 2.68294647 |
| 81 | skeletal muscle fiber development (GO:0048741) | 2.67348329 |
| 82 | sequestering of metal ion (GO:0051238) | 2.67091685 |
| 83 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.66986102 |
| 84 | neutrophil activation (GO:0042119) | 2.66731623 |
| 85 | embryonic process involved in female pregnancy (GO:0060136) | 2.64864925 |
| 86 | negative regulation of protein localization to cell surface (GO:2000009) | 2.63788055 |
| 87 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.63468890 |
| 88 | positive regulation of adherens junction organization (GO:1903393) | 2.63364306 |
| 89 | skeletal muscle adaptation (GO:0043501) | 2.61981468 |
| 90 | positive regulation of protein oligomerization (GO:0032461) | 2.61328252 |
| 91 | positive regulation of nuclease activity (GO:0032075) | 2.60361725 |
| 92 | tetrapyrrole metabolic process (GO:0033013) | 2.60031140 |
| 93 | iron ion import (GO:0097286) | 2.57952207 |
| 94 | mammary gland epithelial cell proliferation (GO:0033598) | 2.54782402 |
| 95 | regulation of metalloenzyme activity (GO:0048552) | 2.54534338 |
| 96 | response to peptidoglycan (GO:0032494) | 2.54297842 |
| 97 | ovulation from ovarian follicle (GO:0001542) | 2.53540137 |
| 98 | ER-nucleus signaling pathway (GO:0006984) | 2.53044080 |
| 99 | protein retention in ER lumen (GO:0006621) | 2.52774303 |
| 100 | cellular response to unfolded protein (GO:0034620) | 2.52720561 |
| 101 | protein targeting to plasma membrane (GO:0072661) | 2.52473939 |
| 102 | striated muscle atrophy (GO:0014891) | 2.51123827 |
| 103 | interferon-gamma secretion (GO:0072643) | 2.50998545 |
| 104 | positive regulation of odontogenesis (GO:0042482) | 2.50979459 |
| 105 | mesodermal cell differentiation (GO:0048333) | 2.50626947 |
| 106 | low-density lipoprotein particle clearance (GO:0034383) | 2.50302865 |
| 107 | endocardial cushion development (GO:0003197) | 2.49279685 |
| 108 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.48596079 |
| 109 | positive regulation of extracellular matrix organization (GO:1903055) | 2.47577210 |
| 110 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.47031196 |
| 111 | regulation of integrin activation (GO:0033623) | 2.46485970 |
| 112 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.44425438 |
| 113 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.44223269 |
| 114 | cellular response to vitamin (GO:0071295) | 2.42363458 |
| 115 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.42029284 |
| 116 | actin-mediated cell contraction (GO:0070252) | 2.41552920 |
| 117 | regulation of translational termination (GO:0006449) | 2.39712618 |
| 118 | respiratory burst (GO:0045730) | 2.39295053 |
| 119 | negative regulation of focal adhesion assembly (GO:0051895) | 2.38578380 |
| 120 | negative regulation of cell junction assembly (GO:1901889) | 2.38578380 |
| 121 | negative regulation of adherens junction organization (GO:1903392) | 2.38578380 |
| 122 | SMAD protein complex assembly (GO:0007183) | 2.38564199 |
| 123 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.37987202 |
| 124 | reactive oxygen species biosynthetic process (GO:1903409) | 2.37794507 |
| 125 | extracellular fibril organization (GO:0043206) | 2.37564421 |
| 126 | wound healing, spreading of cells (GO:0044319) | 2.36904328 |
| 127 | positive regulation of focal adhesion assembly (GO:0051894) | 2.36420402 |
| 128 | positive regulation of cell junction assembly (GO:1901890) | 2.36420402 |
| 129 | hyaluronan catabolic process (GO:0030214) | 2.35877918 |
| 130 | response to UV-C (GO:0010225) | 2.35872648 |
| 131 | negative regulation of fatty acid transport (GO:2000192) | 2.35626014 |
| 132 | heart trabecula formation (GO:0060347) | 2.35008963 |
| 133 | positive regulation of receptor recycling (GO:0001921) | 2.34794353 |
| 134 | muscle cell migration (GO:0014812) | 2.33956151 |
| 135 | cellular response to topologically incorrect protein (GO:0035967) | 2.32961285 |
| 136 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.32545601 |
| 137 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.31591177 |
| 138 | regulation of protein heterodimerization activity (GO:0043497) | 2.31554355 |
| 139 | IMP biosynthetic process (GO:0006188) | 2.30982831 |
| 140 | leukocyte aggregation (GO:0070486) | 2.30464917 |
| 141 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.30432204 |
| 142 | muscle atrophy (GO:0014889) | 2.29479863 |
| 143 | pattern specification involved in kidney development (GO:0061004) | 2.29090140 |
| 144 | negative regulation of necroptotic process (GO:0060546) | 2.28941713 |
| 145 | virion attachment to host cell (GO:0019062) | 2.27948234 |
| 146 | adhesion of symbiont to host cell (GO:0044650) | 2.27948234 |
| 147 | positive regulation of protein homooligomerization (GO:0032464) | 2.27853958 |
| 148 | positive regulation of hemostasis (GO:1900048) | 2.27649624 |
| 149 | positive regulation of blood coagulation (GO:0030194) | 2.27649624 |
| 150 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.22042052 |
| 151 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.21252234 |
| 152 | superoxide anion generation (GO:0042554) | 2.18908705 |
| 153 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.17517136 |
| 154 | RNA stabilization (GO:0043489) | 2.16318842 |
| 155 | mRNA stabilization (GO:0048255) | 2.16318842 |
| 156 | response to muramyl dipeptide (GO:0032495) | 2.16113800 |
| 157 | purine nucleotide salvage (GO:0032261) | 2.15943368 |
| 158 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.14402955 |
| 159 | cellular response to glucose starvation (GO:0042149) | 2.14287239 |
| 160 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.14163051 |
| 161 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.13769567 |
| 162 | platelet formation (GO:0030220) | 2.12687638 |
| 163 | myeloid cell development (GO:0061515) | 2.12434703 |
| 164 | positive regulation of myotube differentiation (GO:0010831) | 2.11471274 |
| 165 | positive regulation of macrophage differentiation (GO:0045651) | 2.11153085 |
| 166 | basement membrane organization (GO:0071711) | 2.09709951 |
| 167 | regulation of podosome assembly (GO:0071801) | 2.08230103 |
| 168 | barbed-end actin filament capping (GO:0051016) | 2.08076234 |
| 169 | myeloid cell homeostasis (GO:0002262) | 2.07407296 |
| 170 | T cell apoptotic process (GO:0070231) | 2.07051853 |
| 171 | plasma membrane repair (GO:0001778) | 2.06705705 |
| 172 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.06302057 |
| 173 | skeletal muscle tissue development (GO:0007519) | 2.05670520 |
| 174 | hydrogen peroxide catabolic process (GO:0042744) | 2.05565056 |
| 175 | positive regulation of osteoblast proliferation (GO:0033690) | 2.05357532 |
| 176 | granulocyte differentiation (GO:0030851) | 2.04673311 |
| 177 | regulation of response to osmotic stress (GO:0047484) | 2.04184119 |
| 178 | extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192) | 2.03732501 |
| 179 | signal transduction in absence of ligand (GO:0038034) | 2.03732501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.87484104 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.77217195 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.73671379 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.70706621 |
| 5 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.14485124 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.02329786 |
| 7 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.89652971 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.77617657 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.56091753 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.48604217 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.45473358 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.31620363 |
| 13 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.19841753 |
| 14 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.17135017 |
| 15 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.13814396 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13544558 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09792767 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.00128190 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96660631 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.90937873 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90410204 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.89508853 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88191190 |
| 24 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.87901301 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.82690877 |
| 26 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.79556375 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76779655 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73025800 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71495771 |
| 30 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.69203078 |
| 31 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.66524210 |
| 32 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.66519735 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.65971107 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64914946 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.64662310 |
| 36 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.60965263 |
| 37 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.60833492 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56614796 |
| 39 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.56408991 |
| 40 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.54758987 |
| 41 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53117049 |
| 42 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53108755 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51578485 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51494696 |
| 45 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.49707575 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.48640573 |
| 47 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.47009511 |
| 48 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.45522035 |
| 49 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.45522035 |
| 50 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.45448147 |
| 51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.42876709 |
| 52 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42528189 |
| 53 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.42475621 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41973997 |
| 55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.41554170 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40945366 |
| 57 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40580426 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40266924 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39830100 |
| 60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38738279 |
| 61 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.38245496 |
| 62 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.36944929 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36506642 |
| 64 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.35474793 |
| 65 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.34943269 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34754090 |
| 67 | * MAF_26560356_Chip-Seq_TH1_Human | 1.34728811 |
| 68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33231073 |
| 69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.33123859 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32486010 |
| 71 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.31531217 |
| 72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31249844 |
| 73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.28159139 |
| 74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27490207 |
| 75 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.25600370 |
| 76 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22446336 |
| 77 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.22389195 |
| 78 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.20904627 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19611948 |
| 80 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19459569 |
| 81 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18842206 |
| 82 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18741772 |
| 83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17998608 |
| 84 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17477838 |
| 85 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.16212628 |
| 86 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15608597 |
| 87 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.15462978 |
| 88 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.14407300 |
| 89 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13196668 |
| 90 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12491934 |
| 91 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12206228 |
| 92 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10946879 |
| 93 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10409057 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10001972 |
| 95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09345052 |
| 96 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08820539 |
| 97 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.08728250 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07527163 |
| 99 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.07253676 |
| 100 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.07114729 |
| 101 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.07053082 |
| 102 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06462299 |
| 103 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05767865 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05651033 |
| 105 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05486952 |
| 106 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05130659 |
| 107 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04928490 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04857840 |
| 109 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04058924 |
| 110 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.03723323 |
| 111 | MYB_26560356_Chip-Seq_TH2_Human | 1.03314015 |
| 112 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02756876 |
| 113 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02069131 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01827972 |
| 115 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01094119 |
| 116 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01078878 |
| 117 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01072718 |
| 118 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00979961 |
| 119 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.00027205 |
| 120 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99136126 |
| 121 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99048845 |
| 122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99036785 |
| 123 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.98735109 |
| 124 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.96265985 |
| 125 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95840562 |
| 126 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95753906 |
| 127 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95396243 |
| 128 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94351189 |
| 129 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93175369 |
| 130 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92638109 |
| 131 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92277763 |
| 132 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.91803813 |
| 133 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91541660 |
| 134 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90828689 |
| 135 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.89480602 |
| 136 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86731748 |
| 137 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84567793 |
| 138 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83691746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 4.62093361 |
| 2 | MP0003950_abnormal_plasma_membrane | 3.19477868 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 2.95280974 |
| 4 | MP0000678_abnormal_parathyroid_gland | 2.66921685 |
| 5 | MP0010307_abnormal_tumor_latency | 2.50430099 |
| 6 | MP0003436_decreased_susceptibility_to | 2.43714186 |
| 7 | MP0005076_abnormal_cell_differentiation | 2.43258659 |
| 8 | MP0004147_increased_porphyrin_level | 2.40692624 |
| 9 | MP0000733_abnormal_muscle_development | 2.31997244 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.22117434 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.02521566 |
| 12 | MP0005397_hematopoietic_system_phenotyp | 2.01597657 |
| 13 | MP0001545_abnormal_hematopoietic_system | 2.01597657 |
| 14 | MP0009840_abnormal_foam_cell | 2.00342540 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 1.98928609 |
| 16 | MP0003566_abnormal_cell_adhesion | 1.97929996 |
| 17 | MP0008004_abnormal_stomach_pH | 1.97261824 |
| 18 | MP0000749_muscle_degeneration | 1.86363645 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 1.85459124 |
| 20 | MP0009278_abnormal_bone_marrow | 1.83317744 |
| 21 | * MP0000858_altered_metastatic_potential | 1.79991457 |
| 22 | MP0000750_abnormal_muscle_regeneration | 1.73991472 |
| 23 | * MP0005501_abnormal_skin_physiology | 1.73463924 |
| 24 | MP0000762_abnormal_tongue_morphology | 1.73179380 |
| 25 | MP0001348_abnormal_lacrimal_gland | 1.67131501 |
| 26 | MP0005257_abnormal_intraocular_pressure | 1.63806429 |
| 27 | MP0003453_abnormal_keratinocyte_physiol | 1.59224679 |
| 28 | MP0000343_altered_response_to | 1.59079665 |
| 29 | MP0006054_spinal_hemorrhage | 1.57942935 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.57848777 |
| 31 | MP0000685_abnormal_immune_system | 1.53570962 |
| 32 | MP0003303_peritoneal_inflammation | 1.52888770 |
| 33 | MP0005023_abnormal_wound_healing | 1.52439541 |
| 34 | MP0009785_altered_susceptibility_to | 1.51723695 |
| 35 | MP0003448_altered_tumor_morphology | 1.49543370 |
| 36 | MP0004510_myositis | 1.48643566 |
| 37 | MP0002796_impaired_skin_barrier | 1.44220211 |
| 38 | MP0001958_emphysema | 1.43620443 |
| 39 | MP0005083_abnormal_biliary_tract | 1.42761937 |
| 40 | MP0000579_abnormal_nail_morphology | 1.40861041 |
| 41 | MP0002419_abnormal_innate_immunity | 1.40445595 |
| 42 | MP0009384_cardiac_valve_regurgitation | 1.38674351 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.35558452 |
| 44 | MP0005508_abnormal_skeleton_morphology | 1.34544521 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.34245162 |
| 46 | MP0001216_abnormal_epidermal_layer | 1.31233425 |
| 47 | MP0003186_abnormal_redox_activity | 1.26958933 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.26735918 |
| 49 | MP0005451_abnormal_body_composition | 1.26088094 |
| 50 | MP0004947_skin_inflammation | 1.25633346 |
| 51 | MP0002254_reproductive_system_inflammat | 1.24150374 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.21164125 |
| 53 | MP0009764_decreased_sensitivity_to | 1.20168117 |
| 54 | MP0000759_abnormal_skeletal_muscle | 1.19801564 |
| 55 | MP0003724_increased_susceptibility_to | 1.19080350 |
| 56 | MP0004272_abnormal_basement_membrane | 1.18606414 |
| 57 | * MP0005000_abnormal_immune_tolerance | 1.18036226 |
| 58 | MP0000747_muscle_weakness | 1.17551602 |
| 59 | MP0002405_respiratory_system_inflammati | 1.17166464 |
| 60 | MP0005165_increased_susceptibility_to | 1.14845268 |
| 61 | MP0002332_abnormal_exercise_endurance | 1.14747660 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.14426659 |
| 63 | MP0003091_abnormal_cell_migration | 1.13732233 |
| 64 | MP0000490_abnormal_crypts_of | 1.13418491 |
| 65 | MP0009250_abnormal_appendicular_skeleto | 1.12648406 |
| 66 | * MP0010771_integument_phenotype | 1.12162724 |
| 67 | MP0005503_abnormal_tendon_morphology | 1.11768379 |
| 68 | MP0000467_abnormal_esophagus_morphology | 1.11365557 |
| 69 | MP0004233_abnormal_muscle_weight | 1.10860202 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.10138371 |
| 71 | MP0004087_abnormal_muscle_fiber | 1.09833944 |
| 72 | MP0005025_abnormal_response_to | 1.09690008 |
| 73 | MP0002896_abnormal_bone_mineralization | 1.07723925 |
| 74 | MP0008007_abnormal_cellular_replicative | 1.05819501 |
| 75 | MP0005275_abnormal_skin_tensile | 1.05699071 |
| 76 | MP0000767_abnormal_smooth_muscle | 1.05545499 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 1.04223473 |
| 78 | MP0002972_abnormal_cardiac_muscle | 1.03015006 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 1.02351751 |
| 80 | MP0009379_abnormal_foot_pigmentation | 1.02062399 |
| 81 | MP0002006_tumorigenesis | 1.01776903 |
| 82 | MP0002106_abnormal_muscle_physiology | 1.01679966 |
| 83 | MP0005164_abnormal_response_to | 1.01363329 |
| 84 | MP0001835_abnormal_antigen_presentation | 0.99349188 |
| 85 | MP0003828_pulmonary_edema | 0.98921329 |
| 86 | MP0001851_eye_inflammation | 0.98572684 |
| 87 | MP0004808_abnormal_hematopoietic_stem | 0.98231636 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.97874533 |
| 89 | MP0010155_abnormal_intestine_physiology | 0.97342028 |
| 90 | MP0006082_CNS_inflammation | 0.96586852 |
| 91 | MP0006138_congestive_heart_failure | 0.96114551 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.94208065 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.94065069 |
| 94 | * MP0001845_abnormal_inflammatory_respons | 0.93715208 |
| 95 | MP0004084_abnormal_cardiac_muscle | 0.93086653 |
| 96 | MP0003941_abnormal_skin_development | 0.91978534 |
| 97 | MP0005390_skeleton_phenotype | 0.91847474 |
| 98 | MP0003279_aneurysm | 0.91212261 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.90821724 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.89769854 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.89750255 |
| 102 | * MP0000350_abnormal_cell_proliferation | 0.89500388 |
| 103 | MP0001915_intracranial_hemorrhage | 0.89011212 |
| 104 | MP0000516_abnormal_urinary_system | 0.88189040 |
| 105 | MP0005367_renal/urinary_system_phenotyp | 0.88189040 |
| 106 | * MP0002452_abnormal_antigen_presenting | 0.87999605 |
| 107 | MP0002060_abnormal_skin_morphology | 0.87785235 |
| 108 | MP0004197_abnormal_fetal_growth/weight/ | 0.87535543 |
| 109 | * MP0002019_abnormal_tumor_incidence | 0.87464916 |
| 110 | MP0009931_abnormal_skin_appearance | 0.87318214 |
| 111 | MP0005369_muscle_phenotype | 0.86266065 |
| 112 | MP0005197_abnormal_uvea_morphology | 0.86078985 |
| 113 | MP0005058_abnormal_lysosome_morphology | 0.85727234 |
| 114 | MP0001542_abnormal_bone_strength | 0.85344351 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.83352808 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.83334433 |
| 117 | MP0002108_abnormal_muscle_morphology | 0.82990290 |
| 118 | MP0002396_abnormal_hematopoietic_system | 0.82952201 |
| 119 | MP0001790_abnormal_immune_system | 0.82499370 |
| 120 | MP0005387_immune_system_phenotype | 0.82499370 |
| 121 | MP0001849_ear_inflammation | 0.80896264 |
| 122 | MP0005330_cardiomyopathy | 0.79999628 |
| 123 | MP0002009_preneoplasia | 0.79341119 |
| 124 | * MP0002398_abnormal_bone_marrow | 0.79247757 |
| 125 | MP0002128_abnormal_blood_circulation | 0.78933249 |
| 126 | * MP0002136_abnormal_kidney_physiology | 0.78711808 |
| 127 | MP0003806_abnormal_nucleotide_metabolis | 0.78566780 |
| 128 | * MP0005621_abnormal_cell_physiology | 0.78091053 |
| 129 | MP0001881_abnormal_mammary_gland | 0.78071790 |
| 130 | * MP0003077_abnormal_cell_cycle | 0.77025578 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.75985668 |
| 132 | MP0003879_abnormal_hair_cell | 0.75381072 |
| 133 | MP0005409_darkened_coat_color | 0.75248056 |
| 134 | * MP0002420_abnormal_adaptive_immunity | 0.74925799 |
| 135 | MP0008260_abnormal_autophagy | 0.74890688 |
| 136 | * MP0001819_abnormal_immune_cell | 0.74863550 |
| 137 | MP0002933_joint_inflammation | 0.74816392 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.74494384 |
| 139 | * MP0002722_abnormal_immune_system | 0.74187612 |
| 140 | MP0003795_abnormal_bone_structure | 0.73490010 |
| 141 | MP0000689_abnormal_spleen_morphology | 0.73443389 |
| 142 | MP0009053_abnormal_anal_canal | 0.72131685 |
| 143 | MP0003075_altered_response_to | 0.72105899 |
| 144 | MP0005193_abnormal_anterior_eye | 0.70853682 |
| 145 | MP0010030_abnormal_orbit_morphology | 0.69449545 |
| 146 | MP0000534_abnormal_ureter_morphology | 0.69125571 |
| 147 | MP0005620_abnormal_muscle_contractility | 0.68074017 |
| 148 | MP0001243_abnormal_dermal_layer | 0.68012814 |
| 149 | MP0001614_abnormal_blood_vessel | 0.66894745 |
| 150 | MP0003385_abnormal_body_wall | 0.66162737 |
| 151 | MP0000249_abnormal_blood_vessel | 0.65629929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.40695260 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 5.32562517 |
| 3 | Nemaline bodies (HP:0003798) | 5.04759792 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 4.91513600 |
| 5 | Poikilocytosis (HP:0004447) | 4.62691293 |
| 6 | Ulnar deviation of the wrist (HP:0003049) | 4.36057504 |
| 7 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.24293861 |
| 8 | Atrophic scars (HP:0001075) | 4.09425104 |
| 9 | Distal arthrogryposis (HP:0005684) | 3.89554517 |
| 10 | Hypochromic microcytic anemia (HP:0004840) | 3.84145037 |
| 11 | Aplasia of the musculature (HP:0100854) | 3.82032865 |
| 12 | Increased mean platelet volume (HP:0011877) | 3.78634231 |
| 13 | Onycholysis (HP:0001806) | 3.73634644 |
| 14 | Menorrhagia (HP:0000132) | 3.60825225 |
| 15 | Reticulocytosis (HP:0001923) | 3.60070231 |
| 16 | Popliteal pterygium (HP:0009756) | 3.59365950 |
| 17 | Round ear (HP:0100830) | 3.36394407 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.34203671 |
| 19 | Malignant hyperthermia (HP:0002047) | 3.30414397 |
| 20 | Fragile skin (HP:0001030) | 3.26531944 |
| 21 | Myopathic facies (HP:0002058) | 3.25604876 |
| 22 | Abnormal platelet volume (HP:0011876) | 3.25123734 |
| 23 | Fetal akinesia sequence (HP:0001989) | 3.24863094 |
| 24 | Abnormality of the neuromuscular junction (HP:0003398) | 3.24382352 |
| 25 | Fatigable weakness (HP:0003473) | 3.24382352 |
| 26 | Upper limb muscle weakness (HP:0003484) | 3.22897435 |
| 27 | Abnormality of placental membranes (HP:0011409) | 3.15071667 |
| 28 | Amniotic constriction ring (HP:0009775) | 3.15071667 |
| 29 | Prolonged bleeding time (HP:0003010) | 3.12553603 |
| 30 | Paralysis (HP:0003470) | 3.09177571 |
| 31 | Increased connective tissue (HP:0009025) | 3.05924849 |
| 32 | Cholelithiasis (HP:0001081) | 2.96919885 |
| 33 | Acanthocytosis (HP:0001927) | 2.91734900 |
| 34 | Deformed tarsal bones (HP:0008119) | 2.86842841 |
| 35 | Absent phalangeal crease (HP:0006109) | 2.84910658 |
| 36 | Type 2 muscle fiber atrophy (HP:0003554) | 2.83847572 |
| 37 | Milia (HP:0001056) | 2.81784562 |
| 38 | Aortic aneurysm (HP:0004942) | 2.79759782 |
| 39 | Recurrent abscess formation (HP:0002722) | 2.78202760 |
| 40 | Calcaneovalgus deformity (HP:0001848) | 2.75748292 |
| 41 | Muscle fiber atrophy (HP:0100295) | 2.73560538 |
| 42 | Abnormal hemoglobin (HP:0011902) | 2.72291977 |
| 43 | Aortic dissection (HP:0002647) | 2.72153345 |
| 44 | Abnormal platelet function (HP:0011869) | 2.69852147 |
| 45 | Impaired platelet aggregation (HP:0003540) | 2.69852147 |
| 46 | Vertebral compression fractures (HP:0002953) | 2.69677235 |
| 47 | Hyporeflexia of lower limbs (HP:0002600) | 2.69593160 |
| 48 | Diaphragmatic weakness (HP:0009113) | 2.69119057 |
| 49 | Vascular tortuosity (HP:0004948) | 2.66913710 |
| 50 | Arterial tortuosity (HP:0005116) | 2.66782054 |
| 51 | Weak cry (HP:0001612) | 2.66778294 |
| 52 | Abnormal gallbladder morphology (HP:0012437) | 2.65412434 |
| 53 | Hyperparathyroidism (HP:0000843) | 2.64176272 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.61060643 |
| 55 | Thin ribs (HP:0000883) | 2.60617075 |
| 56 | Hyperthyroidism (HP:0000836) | 2.58011955 |
| 57 | Hypochromic anemia (HP:0001931) | 2.57496964 |
| 58 | Mesangial abnormality (HP:0001966) | 2.57278975 |
| 59 | Entropion (HP:0000621) | 2.57150606 |
| 60 | Abnormality of the Achilles tendon (HP:0005109) | 2.55255082 |
| 61 | Muscle fiber splitting (HP:0003555) | 2.52304756 |
| 62 | Purpura (HP:0000979) | 2.50868467 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.46871398 |
| 64 | Abnormality of proline metabolism (HP:0010907) | 2.46627816 |
| 65 | Hydroxyprolinuria (HP:0003080) | 2.46627816 |
| 66 | Abnormality of reticulocytes (HP:0004312) | 2.41647014 |
| 67 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.41111750 |
| 68 | Follicular hyperkeratosis (HP:0007502) | 2.40203018 |
| 69 | Tetraparesis (HP:0002273) | 2.39732820 |
| 70 | Fragile nails (HP:0001808) | 2.39063686 |
| 71 | Nail dystrophy (HP:0008404) | 2.37680296 |
| 72 | Pterygium (HP:0001059) | 2.36579875 |
| 73 | Achilles tendon contracture (HP:0001771) | 2.35614353 |
| 74 | Ankyloglossia (HP:0010296) | 2.35214088 |
| 75 | Hypertensive crisis (HP:0100735) | 2.34040272 |
| 76 | Abnormality of the calcaneus (HP:0008364) | 2.33211437 |
| 77 | Abnormality of the tricuspid valve (HP:0001702) | 2.32623559 |
| 78 | Abnormality of nail color (HP:0100643) | 2.32445720 |
| 79 | Distal lower limb amyotrophy (HP:0008944) | 2.32313516 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.32282380 |
| 81 | Increased serum ferritin (HP:0003281) | 2.30393915 |
| 82 | Bladder diverticulum (HP:0000015) | 2.29728265 |
| 83 | Alopecia of scalp (HP:0002293) | 2.28546915 |
| 84 | Squamous cell carcinoma (HP:0002860) | 2.27320497 |
| 85 | Frequent falls (HP:0002359) | 2.27280071 |
| 86 | Urticaria (HP:0001025) | 2.26359907 |
| 87 | Easy fatigability (HP:0003388) | 2.25996302 |
| 88 | Nephritis (HP:0000123) | 2.25612626 |
| 89 | Pustule (HP:0200039) | 2.24725035 |
| 90 | Hip contracture (HP:0003273) | 2.22628087 |
| 91 | Focal segmental glomerulosclerosis (HP:0000097) | 2.21855062 |
| 92 | Difficulty climbing stairs (HP:0003551) | 2.21810067 |
| 93 | Mediastinal lymphadenopathy (HP:0100721) | 2.21597545 |
| 94 | Ulnar bowing (HP:0003031) | 2.20406175 |
| 95 | Upper limb amyotrophy (HP:0009129) | 2.20109702 |
| 96 | Distal upper limb amyotrophy (HP:0007149) | 2.20109702 |
| 97 | Slender build (HP:0001533) | 2.19951677 |
| 98 | Epistaxis (HP:0000421) | 2.19698369 |
| 99 | Spinal rigidity (HP:0003306) | 2.19361771 |
| 100 | Long clavicles (HP:0000890) | 2.18353552 |
| 101 | Abnormal finger flexion creases (HP:0006143) | 2.18013900 |
| 102 | Mitral stenosis (HP:0001718) | 2.17330533 |
| 103 | Vascular calcification (HP:0004934) | 2.16608408 |
| 104 | EMG: myopathic abnormalities (HP:0003458) | 2.13383986 |
| 105 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.13195285 |
| 106 | Microcytic anemia (HP:0001935) | 2.12553040 |
| 107 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.12266263 |
| 108 | Cervical subluxation (HP:0003308) | 2.11804057 |
| 109 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10739678 |
| 110 | Recurrent bacterial skin infections (HP:0005406) | 2.09678961 |
| 111 | Wormian bones (HP:0002645) | 2.08869472 |
| 112 | Premature rupture of membranes (HP:0001788) | 2.07361151 |
| 113 | Bulbar palsy (HP:0001283) | 2.07064464 |
| 114 | Hypoalbuminemia (HP:0003073) | 2.06975043 |
| 115 | Abnormal albumin level (HP:0012116) | 2.06975043 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 2.06548044 |
| 117 | Insomnia (HP:0100785) | 2.06425395 |
| 118 | Neonatal respiratory distress (HP:0002643) | 2.06011786 |
| 119 | Generalized muscle weakness (HP:0003324) | 2.04381364 |
| 120 | Thick nail (HP:0001805) | 2.02495085 |
| 121 | Mitral regurgitation (HP:0001653) | 2.02345476 |
| 122 | Ankle contracture (HP:0006466) | 2.01931622 |
| 123 | Increased variability in muscle fiber diameter (HP:0003557) | 2.00656356 |
| 124 | Metaphyseal cupping (HP:0003021) | 2.00650717 |
| 125 | Blue sclerae (HP:0000592) | 2.00612983 |
| 126 | Ileus (HP:0002595) | 2.00309756 |
| 127 | Gowers sign (HP:0003391) | 1.98051619 |
| 128 | Elbow flexion contracture (HP:0002987) | 1.96500343 |
| 129 | Cystic hygroma (HP:0000476) | 1.96017764 |
| 130 | Short middle phalanx of the 5th finger (HP:0004220) | 1.95918162 |
| 131 | Glomerulonephritis (HP:0000099) | 1.94886167 |
| 132 | Abnormality of oral frenula (HP:0000190) | 1.93406742 |
| 133 | Osteolytic defects of the hand bones (HP:0009699) | 1.92552288 |
| 134 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92552288 |
| 135 | Polycythemia (HP:0001901) | 1.90551788 |
| 136 | Natal tooth (HP:0000695) | 1.89380440 |
| 137 | Abnormality of macrophages (HP:0004311) | 1.89319455 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88199840 |
| 139 | Akinesia (HP:0002304) | 1.85975721 |
| 140 | Oligodontia (HP:0000677) | 1.83502888 |
| 141 | Cutaneous photosensitivity (HP:0000992) | 1.82948363 |
| 142 | Abnormal blistering of the skin (HP:0008066) | 1.82940945 |
| 143 | Nausea (HP:0002018) | 1.82839776 |
| 144 | Neonatal short-limb short stature (HP:0008921) | 1.82080082 |
| 145 | Deep venous thrombosis (HP:0002625) | 1.82023694 |
| 146 | Spondylolisthesis (HP:0003302) | 1.81694609 |
| 147 | Myocardial infarction (HP:0001658) | 1.81691097 |
| 148 | Lip pit (HP:0100267) | 1.80812299 |
| 149 | Plantar hyperkeratosis (HP:0007556) | 1.78040722 |
| 150 | Cholecystitis (HP:0001082) | 1.77498697 |
| 151 | Abnormal gallbladder physiology (HP:0012438) | 1.77498697 |
| 152 | Gingivitis (HP:0000230) | 1.77203376 |
| 153 | Short nail (HP:0001799) | 1.77122275 |
| 154 | Petechiae (HP:0000967) | 1.76957689 |
| 155 | Hypoplasia of dental enamel (HP:0006297) | 1.76901196 |
| 156 | Trismus (HP:0000211) | 1.76570588 |
| 157 | Lower limb amyotrophy (HP:0007210) | 1.76095361 |
| 158 | Atelectasis (HP:0100750) | 1.73169094 |
| 159 | Protrusio acetabuli (HP:0003179) | 1.72447191 |
| 160 | Osteomalacia (HP:0002749) | 1.72159773 |
| 161 | Bruising susceptibility (HP:0000978) | 1.72107290 |
| 162 | Venous abnormality (HP:0002624) | 1.71695022 |
| 163 | Interstitial pulmonary disease (HP:0006530) | 1.71470436 |
| 164 | Ridged nail (HP:0001807) | 1.71346469 |
| 165 | Hyperphosphatemia (HP:0002905) | 1.70825687 |
| 166 | Abnormality of the acetabulum (HP:0003170) | 1.70605116 |
| 167 | Generalized amyotrophy (HP:0003700) | 1.69869913 |
| 168 | Dilatation of the ascending aorta (HP:0005111) | 1.65954850 |
| 169 | Hypercortisolism (HP:0001578) | 1.65351531 |
| 170 | Poikiloderma (HP:0001029) | 1.64266310 |
| 171 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.64068957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 3.13604404 |
| 2 | LATS2 | 2.75626463 |
| 3 | EPHA2 | 2.74425680 |
| 4 | EIF2AK1 | 2.57938970 |
| 5 | PIM1 | 2.41068867 |
| 6 | MAP3K14 | 2.26693971 |
| 7 | ARAF | 2.22995850 |
| 8 | TAOK2 | 2.19065806 |
| 9 | TRIB3 | 2.17127211 |
| 10 | ERN1 | 2.09212858 |
| 11 | BMX | 2.07209867 |
| 12 | PIM2 | 2.04983938 |
| 13 | STK10 | 2.03372174 |
| 14 | TRPM7 | 2.02655212 |
| 15 | PRPF4B | 2.01120267 |
| 16 | EIF2AK3 | 1.98406532 |
| 17 | MST1R | 1.95161439 |
| 18 | CDK12 | 1.92722352 |
| 19 | ZAK | 1.82854646 |
| 20 | TGFBR2 | 1.77045545 |
| 21 | TBK1 | 1.75463141 |
| 22 | SIK1 | 1.72880909 |
| 23 | MAP3K10 | 1.71871683 |
| 24 | NTRK1 | 1.67598088 |
| 25 | MAPKAPK3 | 1.67471331 |
| 26 | PIK3CG | 1.66918181 |
| 27 | EPHB1 | 1.66001017 |
| 28 | TLK1 | 1.63475523 |
| 29 | STK4 | 1.60459898 |
| 30 | PAK4 | 1.58124019 |
| 31 | PAK2 | 1.57289900 |
| 32 | IKBKB | 1.55975024 |
| 33 | MOS | 1.53293957 |
| 34 | MAP2K3 | 1.52986445 |
| 35 | CHUK | 1.49581518 |
| 36 | IKBKE | 1.48006266 |
| 37 | TTN | 1.47331934 |
| 38 | MST4 | 1.46813321 |
| 39 | CDK6 | 1.44695846 |
| 40 | MAP3K3 | 1.41624032 |
| 41 | DYRK3 | 1.40012280 |
| 42 | IRAK3 | 1.36750713 |
| 43 | DMPK | 1.33147684 |
| 44 | PDK2 | 1.25885528 |
| 45 | LMTK2 | 1.24262448 |
| 46 | MAP3K9 | 1.22418797 |
| 47 | RPS6KA4 | 1.22070878 |
| 48 | ILK | 1.21534776 |
| 49 | NME2 | 1.21144740 |
| 50 | ICK | 1.19912348 |
| 51 | LATS1 | 1.19030811 |
| 52 | MAP3K12 | 1.18714405 |
| 53 | MUSK | 1.18504529 |
| 54 | PKN2 | 1.18442763 |
| 55 | EEF2K | 1.15615308 |
| 56 | OBSCN | 1.11655650 |
| 57 | RPS6KB2 | 1.11501955 |
| 58 | STK3 | 1.09688173 |
| 59 | LRRK2 | 1.06678239 |
| 60 | FLT3 | 1.05170952 |
| 61 | MET | 1.04724953 |
| 62 | NEK9 | 1.00086076 |
| 63 | TESK1 | 0.99774680 |
| 64 | NEK1 | 0.97868456 |
| 65 | CDK8 | 0.97558470 |
| 66 | TAOK3 | 0.97395371 |
| 67 | AKT3 | 0.96435045 |
| 68 | MAP3K11 | 0.94057737 |
| 69 | PBK | 0.93860362 |
| 70 | MAP3K13 | 0.92441143 |
| 71 | MAP2K1 | 0.88571323 |
| 72 | MAPKAPK2 | 0.88416265 |
| 73 | JAK2 | 0.88183257 |
| 74 | BRAF | 0.87134867 |
| 75 | IRAK4 | 0.86502879 |
| 76 | PTK6 | 0.85876719 |
| 77 | DDR2 | 0.85371804 |
| 78 | MAP3K8 | 0.83444533 |
| 79 | RPS6KA5 | 0.83353670 |
| 80 | ABL2 | 0.77693774 |
| 81 | TEC | 0.77122236 |
| 82 | AKT2 | 0.76894561 |
| 83 | DYRK1B | 0.76676257 |
| 84 | PAK1 | 0.76667431 |
| 85 | EIF2AK2 | 0.75816890 |
| 86 | NME1 | 0.74794295 |
| 87 | RIPK4 | 0.71763835 |
| 88 | RIPK1 | 0.70233248 |
| 89 | JAK1 | 0.69852170 |
| 90 | JAK3 | 0.69849976 |
| 91 | MAP3K1 | 0.69116638 |
| 92 | PTK2 | 0.67572552 |
| 93 | PTK2B | 0.66338542 |
| 94 | MARK3 | 0.66318639 |
| 95 | MELK | 0.66098468 |
| 96 | HIPK2 | 0.65824254 |
| 97 | DAPK3 | 0.65212579 |
| 98 | CSK | 0.65112823 |
| 99 | SCYL2 | 0.64575817 |
| 100 | NEK2 | 0.64005727 |
| 101 | MAP3K6 | 0.63677807 |
| 102 | GRK6 | 0.63103285 |
| 103 | PRKD2 | 0.62971429 |
| 104 | ZAP70 | 0.62683954 |
| 105 | SMG1 | 0.61706127 |
| 106 | FRK | 0.61631706 |
| 107 | TYK2 | 0.61292877 |
| 108 | KSR2 | 0.60832618 |
| 109 | MAPK11 | 0.57251421 |
| 110 | AURKB | 0.56943516 |
| 111 | BRSK2 | 0.56597442 |
| 112 | CLK1 | 0.54508877 |
| 113 | RAF1 | 0.54404105 |
| 114 | PRKG2 | 0.54012413 |
| 115 | KSR1 | 0.53790769 |
| 116 | STK38 | 0.53685166 |
| 117 | CDK4 | 0.53611275 |
| 118 | ERBB4 | 0.53047115 |
| 119 | MAP3K5 | 0.52353442 |
| 120 | BLK | 0.52238729 |
| 121 | PDGFRA | 0.51175543 |
| 122 | RPS6KA2 | 0.50636105 |
| 123 | CDK9 | 0.49868284 |
| 124 | ROCK1 | 0.49087662 |
| 125 | GSK3A | 0.48838315 |
| 126 | SIK3 | 0.48137664 |
| 127 | EPHB2 | 0.46525862 |
| 128 | LIMK1 | 0.45425957 |
| 129 | KIT | 0.44795381 |
| 130 | MTOR | 0.44457226 |
| 131 | MAPK12 | 0.41743288 |
| 132 | RPS6KC1 | 0.41403386 |
| 133 | RPS6KL1 | 0.41403386 |
| 134 | PDPK1 | 0.41347694 |
| 135 | PDGFRB | 0.41299207 |
| 136 | AURKA | 0.40898477 |
| 137 | ABL1 | 0.39681361 |
| 138 | STK24 | 0.39671474 |
| 139 | RPS6KA6 | 0.39593176 |
| 140 | ROCK2 | 0.35472543 |
| 141 | STK16 | 0.34270018 |
| 142 | MAPK4 | 0.32496570 |
| 143 | ADRBK1 | 0.31893688 |
| 144 | CAMK2G | 0.31432668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.31163420 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.65843065 |
| 3 | Prion diseases_Homo sapiens_hsa05020 | 2.54855324 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41979824 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.24438713 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.01945519 |
| 7 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.92010789 |
| 8 | Bladder cancer_Homo sapiens_hsa05219 | 1.89645069 |
| 9 | * Apoptosis_Homo sapiens_hsa04210 | 1.82456723 |
| 10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.69586507 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.65913897 |
| 12 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.62757622 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62504742 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57945484 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57540414 |
| 16 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.57305636 |
| 17 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.52326805 |
| 18 | Amoebiasis_Homo sapiens_hsa05146 | 1.50201100 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47732527 |
| 20 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46818985 |
| 21 | * p53 signaling pathway_Homo sapiens_hsa04115 | 1.45275759 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45008393 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42045399 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.40646526 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.39376533 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.37540939 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.34298461 |
| 28 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.32835306 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31733369 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.27891896 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.27247842 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.26275748 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26075571 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.19414474 |
| 35 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.19224700 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.18055324 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.16611149 |
| 38 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.16368728 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.14915840 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14643248 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13187316 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.10485492 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.09432782 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09342100 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09145602 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08045389 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.06039833 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.05643352 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04862069 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 1.04800005 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.04570759 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04538850 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02746194 |
| 54 | Prostate cancer_Homo sapiens_hsa05215 | 1.01925625 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01153077 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 1.00570820 |
| 57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95727406 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.95506033 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93256086 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93004741 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92971373 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92616262 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92273895 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91384265 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.90648410 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.89175063 |
| 67 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.88725686 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88033887 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87350899 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85416450 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84627127 |
| 72 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84515112 |
| 73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83940928 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83563357 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81443524 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.81237210 |
| 77 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79479782 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79008558 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78588487 |
| 80 | * Cell cycle_Homo sapiens_hsa04110 | 0.77529775 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.76908259 |
| 82 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76647839 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.76198408 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.76071853 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75709568 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74015574 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73865928 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.73501082 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72918284 |
| 90 | Glioma_Homo sapiens_hsa05214 | 0.72097303 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71750536 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70655777 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70104669 |
| 94 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70052023 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68912048 |
| 96 | Melanoma_Homo sapiens_hsa05218 | 0.68616813 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67855153 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66362019 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65159428 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64025988 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62000168 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60626701 |
| 103 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60439441 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.59244330 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58057730 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57861781 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57500255 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57427293 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56053294 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51890156 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51845437 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51647499 |
| 113 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51640377 |
| 114 | Tight junction_Homo sapiens_hsa04530 | 0.50787134 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49486874 |
| 116 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49476390 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49466416 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48984332 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48702054 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48657536 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48566792 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48469939 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48180173 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47701852 |
| 125 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45123010 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44962464 |
| 127 | DNA replication_Homo sapiens_hsa03030 | 0.44778274 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44508643 |
| 129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44241718 |
| 130 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42457080 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42287710 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42119911 |

